Combinatorial of anti-CD73 together with PSB1115 further improved tumor control and inclusion of A2A and A2B antagonists with CD73-neutralization markedly restrained tumor progression leading to complete tumor elimination in some mice (Fig. 6e). The gene discussed is NT5E; the disease is neoplasm.